IP Library Granted Patent US 7,888,053
Granted Patent B2
US 7,888,053 · App. 12/550,603 · Granted Feb 15, 2011

Making encoded ghost cells for multiplexed detection of anti-red cell alloantibodies

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,888,053
App. No.
12/550,603
Granted
Feb 15, 2011
Kind
B2
Abstract

Disclosed are methods for detecting antibody in a sample, where the antibody targets an antigen expressed by red blood cells or red blood cell ghosts. Rather than detecting the binding events between a particular antigen antibody pair (as in traditional agglutination based assays) the methods herein allow for multiplexed detection of clinically important allo-immune antibodies to blood group antigens. Specifically the method involves generating fluorescently encoded red blood cells or red blood cell ghosts with known antigen presentation and using them to detect the presence of antibody in serum/plasma with a fluorescent sandwich type immunoassay. The assay results can be read using flow cytometric or fluorescent microscope based imaging techniques.

Claims (15)

1. A method of preparing encoded ghost cells comprising:

separating erythrocytes from whole blood;

incubating the erythrocytes with a dye solution, wherein the dye solution contains two or more fluorescent dyes mixed at a predetermined ratio which upon excitation exhibit distinct fluorescent emission signals, wherein the ratio of the fluorescent emission signals is governed by said predetermined ratio;

lysing the erythrocytes in the dye solution by adding a lysing solution;

re-sealing the lysed erythrocytes by adding a re-sealing solution; and

separating the re-sealed erythrocytes to give encoded ghost cells.

2. The method of claim 1 wherein separation of the erythrocytes and the re-sealed erythrocytes is performed by centrifugation.

3. The method of claim 1 wherein the lysing solution comprises the following:

0.69 g of Monosodium Phosphate, 0.203 g of magnesium chloride hexahydrate and 0.0435 g of phenylmethylsulfonylchloride dissolved in 500 ml of distilled water.

4. The method of claim 1 wherein the re-sealing solution comprises 6 g of sodium chloride dissolved in 50 ml of distilled water.

5. The method of claim 1 wherein the dye solution is a buffer having pH near neutral, approximately isotonic ionic strength, and Magnesium ions at a concentration of 0.1 to 2 mM.

6. The method of claim 1 wherein the dye is fluorescent.

7. The method of claim 1 further comprising the step of storing the ghost cells in a solution comprising:

4.383 g of sodium chloride, 0.345 g Monosodium Phosphate, 0.203 g of magnesium chloride hexahydrate, and 0.0435 g of phenylmethylsulfonylchloride, dissolved in 500 ml of distilled water.

8. Encoded ghost cells prepared by the method of any of claims 1 or 2 to 6 .

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Mar 15, 2023
From: ALTER DOMUS (US) LLC, AS COLLATERAL AGENT
To: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; SIRONA GENOMICS, INC.; IMMUCOR GTI DIAGNOSTICS, INC.
Reel/Frame 063090/0111 →
RELEASE OF SECURITY INTEREST Recorded Mar 15, 2023
From: HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT
To: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; SIRONA GENOMICS, INC.; IMMUCOR GTI DIAGNOSTICS, INC.
Reel/Frame 063090/0033 →
SECURITY INTEREST Recorded Jul 2, 2020
From: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; SIRONA GENOMICS, INC.; IMMUCOR GTI DIAGNOSTICS INC.
To: ALTER DOMUS (US) LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 053119/0152 →
SECURITY INTEREST Recorded Jul 2, 2020
From: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; SIRONA GENOMICS, INC.; IMMUCOR GTI DIAGNOSTICS INC.
To: HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 053119/0135 →
RELEASE OF PATENT SECURITY INTERESTS Recorded Jul 2, 2020
From: CITIBANK, N.A.
To: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; IMMUCOR GTI DIAGNOSTICS, INC.; SIRONA GENONICS, INC.
Reel/Frame 053121/0935 →
PATENT SECURITY AGREEMENT Recorded Aug 19, 2011
From: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 026778/0640 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2010
From: BANERJEE, SUKANTA
To: BIOARRAY SOLUTIONS LTD.,
Reel/Frame 024599/0098 →